NOLVAMED 20 (Tamoxifen Citrate), manufactured by Deus Medical, is a Selective Estrogen Receptor Modulator (SERM) used for several medical purposes:
Treatment of Metastatic Breast Cancer: NOLVAMED 20 is employed in the management of metastatic breast cancer.
Adjuvant Treatment of Breast Cancer: It serves as an adjuvant therapy for breast cancer.
Palliative Treatment for Premenopausal Women with ER-Positive Disease: NOLVAMED 20 is also utilized for the palliative treatment of premenopausal women with ER-positive disease.
Key Details:
CAS Number: 54965-24-1
Molecular Weight: 563.63 g/mol
Formula: C32H34NO8
Mechanism of Action:
As a SERM, tamoxifen (the active component in NOLVAMED 20) inhibits estrogen by preventing it from binding to its receptor.
This inhibition leads to decreased tumor growth and proliferation.
Additionally, tamoxifen induces cell death in cells with estrogen receptors.
Dosage:
Take 20mg of tamoxifen daily, orally.
Possible Side Effects:
Endometrial cancer
Liver disease
Cardiovascular and metabolic disorders
Postmenopausal bleeding
Vision problems
Stroke and pulmonary embolism
Interactions:
Be cautious when using NOLVAMED 20 alongside medications such as butalbital, cimetidine, secobarbital, SSRI antidepressants, warfarin, hormonal contraceptives, and antiseizure medications.
Composition:
Tamoxifen citrate: 20mg
Excipients: As needed
Unlock hormonal balance with NOLVAMED 20mg by Deus Medical. Crafted with precision and featuring Tamoxifen Citrate, it delicately engages estrogen receptors, promoting well-being and stability.
